Comparison of Three Methods of Hemoglobin Monitoring

This study is not yet open for participant recruitment.

Verified by University of California, San Francisco, November 2008

Sponsored by:	University of California, San Francisco
Information provided by:	University of California, San Francisco
ClinicalTrials.gov Identifier:	NCT00792597

Purpose

The purpose of this study is to compare the hemoglobin results obtained with 1) the HemoCue™, 2) the Masimo SpHb™, and 3) the UCSF Clinical Laboratory. The goal is to determine if these three values differ from each other during various levels of blood loss in the clinical care of patients for spine revision and hip revision surgery.

Condition
Blood Loss

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case Control, Prospective
Official Title:	Comparison of Three Methods of Hemoglobin Monitoring in Patients Undergoing Spine Revision or Hip Revision Surgery.

Further study details as provided by University of California, San Francisco:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:

Groups/Cohorts
spine or hip surgery

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

See inclusion/exclusion criteria

Criteria

Inclusion Criteria:

Male or non-pregnant female 18 y/o or older
ASA Classificiation 1, 2 or 3
Scheduled to undergo spine or hip revision surgery

Exclusion Criteria:

Pregnant or nursing
Patients who in the study investigators clinical judgement would not be suitable for research.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00792597

Contacts

Contact: Ronald D Miller, MD	(415) 476-9035	millerr@anesthesia.ucsf.edu
Contact: Theresa A Ward, RN	(415) 514-0685	wardt@anesthesia.ucsf.edu

Locations

United States, California
University of California San Francisco
San Francisco, California, United States, 94143

Sponsors and Collaborators

University of California, San Francisco

Investigators

Study Director:

Ronald D Miller, MD

University of California, San Francisco

More Information

Responsible Party:	University of California San Francisco ( Matthias Braehler, MD )
Study ID Numbers:	H60602-33092
Study First Received:	November 14, 2008
Last Updated:	November 17, 2008
ClinicalTrials.gov Identifier:	NCT00792597
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Hemorrhage

ClinicalTrials.gov processed this record on January 15, 2009